Chearwae, Wanida; Bright, John J (2008) 15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. J Clin Immunol 28:558-70
|
Mo, Caiqing; Chearwae, Wanida; O'Malley, John T et al. (2008) Stat4 isoforms differentially regulate inflammation and demyelination in experimental allergic encephalomyelitis. J Immunol 181:5681-90
|
Rajasingh, Johnson; Bright, John J (2006) 15-Deoxy-delta12,14-prostaglandin J2 regulates leukemia inhibitory factor signaling through JAK-STAT pathway in mouse embryonic stem cells. Exp Cell Res 312:2538-46
|
Muthian, Gladson; Raikwar, Himanshu P; Rajasingh, Johnson et al. (2006) 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. J Neurosci Res 83:1299-309
|
Rajasingh, Johnson; Raikwar, Himanshu P; Muthian, Gladson et al. (2006) Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem Biophys Res Commun 340:359-68
|
Raikwar, Himanshu P; Muthian, Gladson; Rajasingh, Johnson et al. (2006) PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2. J Neuroimmunol 178:76-86
|
Muthian, Gladson; Pradeep, Chellappan G; Sargapradeep, Kuttappan et al. (2006) Setaria digitata secreted filarial lipids modulate IL-12 signaling through JAK-STAT pathway leading to the development of Th1 response. Exp Parasitol 114:193-203
|
Muthian, Gladson; Raikwar, Himanshu P; Johnson, Caroline et al. (2006) COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis. J Clin Immunol 26:73-85
|
Raikwar, Himanshu P; Muthian, Gladson; Rajasingh, Johnson et al. (2005) PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis. J Neuroimmunol 167:99-107
|
Bright, John J (2004) Targeting autoimmune diseases through nutraceuticals. Nutrition 20:39-43
|
Showing the most recent 10 out of 14 publications